Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 768.55
+6.80 (0.89%)
At close: Jan 22, 2026
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 151.24 billion as of January 23, 2026. Its market cap has decreased by -27.79% in one year.
Market Cap
151.24B
Enterprise Value
164.66B
Revenue
70.83B
Ranking
n/a
PE Ratio
23.84
Stock Price
768.55
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 151.24B, an increase of 1,580.09%. That is a compound annual growth rate of 21.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 150.28B | -9.64% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 294.79B |
| AstraZeneca Pharma India | 206.24B |
| Jubilant Pharmova | 150.52B |
| Caplin Point Laboratories | 137.79B |
| Granules India | 134.12B |
| Rubicon Research | 109.30B |
| Sanofi India | 93.47B |
| CORONA Remedies | 92.12B |